Literature DB >> 9784520

Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.

M Thakker1, J S Park, V Carey, J C Lee.   

Abstract

Controversy persists over the role that the capsular polysaccharide plays in the pathogenesis of Staphylococcus aureus infections. To address this issue, we compared the mouse virulence of S. aureus Reynolds and capsule-defective mutant strains cultivated under conditions of high or low capsule expression. Strain Reynolds cells cultivated on Columbia salt agar plates expressed approximately 100-fold more type 5 capsular polysaccharide than did cells cultivated in Columbia salt broth. The relative virulence of strain Reynolds and its capsule-defective mutants after growth on either solid or liquid medium was examined in mice challenged intraperitoneally or intravenously. The results indicated that agar-grown Reynolds cells were cleared from the bloodstream of mice less readily than broth-grown Reynolds cells. When the parental and mutant strains were cultivated on solid medium, strain Reynolds sustained a higher level of bacteremia than did the capsular mutants. We performed in vitro opsonophagocytic killing assays to determine whether staphylococcal virulence for mice correlated with resistance to phagocytosis. S. aureus Reynolds cultivated on solid medium was susceptible to phagocytic killing only in the presence of specific capsular antibodies and complement. Strain Reynolds grown in broth showed opsonic requirements for phagocytic killing that were similar to those of the capsular mutants (grown in broth or on agar); i.e., the bacteria were opsonized for phagocytosis by nonimmune serum with complement activity. These studies indicate that optimal expression of capsule enhances bacterial virulence in the mouse model of bacteremia, probably by rendering the organisms resistant to opsonophagocytic killing by leukocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784520      PMCID: PMC108646     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Regulation of exoprotein gene expression in Staphylococcus aureus by agar.

Authors:  P Recsei; B Kreiswirth; M O'Reilly; P Schlievert; A Gruss; R P Novick
Journal:  Mol Gen Genet       Date:  1986-01

2.  Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types.

Authors:  D Sompolinsky; Z Samra; W W Karakawa; W F Vann; R Schneerson; Z Malik
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

3.  Correlation between the production of alpha-toxin and growth rate in Staphylococcus aureus.

Authors:  K Totake; Y Ichikawa
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

4.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  W W Karakawa; A Sutton; R Schneerson; A Karpas; W F Vann
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.

Authors:  R D Arbeit; W W Karakawa; W F Vann; J B Robbins
Journal:  Diagn Microbiol Infect Dis       Date:  1984-04       Impact factor: 2.803

7.  Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.

Authors:  H A Verbrugh; R Peters; M Rozenberg-Arska; P K Peterson; J Verhoef
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

8.  Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media.

Authors:  A L Cheung; V A Fischetti
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.

Authors:  H A Verbrugh; P K Peterson; B Y Nguyen; S P Sisson; Y Kim
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

10.  Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.

Authors:  H K Hochkeppel; D G Braun; W Vischer; A Imm; S Sutter; U Staeubli; R Guggenheim; E L Kaplan; A Boutonnier; J M Fournier
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  99 in total

1.  Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA.

Authors:  Thanh Luong; Subrata Sau; Marisa Gomez; Jean C Lee; Chia Y Lee
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.

Authors:  D O Sordelli; F R Buzzola; M I Gomez; L Steele-Moore; D Berg; E Gentilini; M Catalano; A J Reitz; T Tollersrud; G Denamiel; P Jeric; J C Lee
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

Review 4.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

5.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

6.  Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2).

Authors:  S Herbert; S W Newell; C Lee; K P Wieland; B Dassy; J M Fournier; C Wolz; G Döring
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

7.  MsaB activates capsule production at the transcription level in Staphylococcus aureus.

Authors:  Justin L Batte; Dhritiman Samanta; Mohamed O Elasri
Journal:  Microbiology       Date:  2016-01-18       Impact factor: 2.777

8.  The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence.

Authors:  Soila Sukupolvi-Petty; Susan Grass; Joseph W St Geme
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

9.  Staphylococcus aureus virulence attenuation and immune clearance mediated by a phage lysin-derived protein.

Authors:  Hang Yang; Jingjing Xu; Wuyou Li; Shujuan Wang; Junhua Li; Junping Yu; Yuhong Li; Hongping Wei
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

10.  Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.

Authors:  Jong-Ho Lee; Na-Hyang Kim; Volker Winstel; Kenji Kurokawa; Jesper Larsen; Jang-Hyun An; Adnan Khan; Min-Young Seong; Min Ja Lee; Paal Skytt Andersen; Andreas Peschel; Bok Luel Lee
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.